FusionPharm Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2006	FY 2005
Period Ending	Mar '12 Mar 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Revenue	0.33	0.26	0	0.02	0
Revenue Growth (YoY)	7824.18%	122230.95%	-99.06%	383.24%	-
Cost of Revenue	0.26	0.22	0	0.01	0
Gross Profit	0.07	0.03	0	0.01	0
Selling, General & Admin	0.41	0.31	0.01	0.13	0.05
Operating Expenses	0.43	0.32	0.01	0.13	0.05
Operating Income	-0.36	-0.29	-0.01	-0.11	-0.05
Interest Expense	-0	-0	-	-0.04	-0.02
Interest & Investment Income	0	0	-	-	-
Other Non Operating Income (Expenses)	-0	-	0	-0.07	-
EBT Excluding Unusual Items	-0.36	-0.29	-0.01	-0.22	-0.07
Other Unusual Items	-	-	0.88	-	-
Pretax Income	-0.36	-0.29	0.87	-0.22	-0.07
Net Income	-0.36	-0.29	0.87	-0.22	-0.07
Net Income to Common	-0.36	-0.29	0.87	-0.22	-0.07
Shares Outstanding (Basic)	2	2	1	-	-
Shares Outstanding (Diluted)	2	2	1	-	-
Shares Change (YoY)	-	146.71%	-	-	-
EPS (Basic)	-0.15	-0.14	1.01	-	-
EPS (Diluted)	-0.15	-0.14	1.01	-	-
Free Cash Flow	-0.38	-0.33	0.85	-0.17	-
Free Cash Flow Per Share	-0.15	-0.15	0.98	-	-
Gross Margin	20.39%	13.31%	60.48%	61.32%	61.02%
Operating Margin	-110.82%	-112.07%	-3579.05%	-509.11%	-991.62%
Profit Margin	-110.72%	-111.94%	414572.38%	-995.58%	-1492.45%
Free Cash Flow Margin	-115.73%	-126.88%	402943.81%	-783.58%	-
EBITDA	-	-0.27	-	-	-
EBITDA Margin	-	-106.88%	-	-	-
D&A For EBITDA	-	0.01	-	-	-
EBIT	-0.36	-0.29	-0.01	-0.11	-0.05
EBIT Margin	-110.82%	-112.07%	-	-	-
Revenue as Reported	-	-	-	0.02	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.